New Leadership at Andreas Hettich GmbH

After 20 years of successful leadership by the Eberle family, the Hettich Group is entering a new, forward-looking phase

31-Mar-2025
Andreas Hettich GmbH

(From left to right) Ralf Ledda, Christoph Pabst & Leopold Frank – The new leadership trio steering the Hettich Group into the future.

The Hettich Group is embarking on a new era of leadership as it restructures its management team for long-term growth and innovation. After two decades of successful leadership by the Eberle family, the company is implementing a forward-looking realignment set to take effect on April 1, 2025.

Andreas Hettich GmbH

Kristina Eberle & Klaus-Günter Eberle – Passing on leadership responsibilities and transitioning to advisory roles within the Hettich Group.

A strong leadership team for the future

The newly appointed CEO, Ralf Ledda, has over 25 years of management experience in leading companies in the healthcare industry. He brings extensive expertise and a proven track record in corporate leadership.

Joining him in this new leadership structure are Leopold Frank and Christoph Pabst, who will assume executive management roles. Together, this dynamic leadership team will provide a strong foundation for the company's continued expansion and sustainability.

Smooth transition and continued strategic focus

The current Managing Directors, Klaus-Günter and Kristina Eberle, will remain actively involved in the company during a transition period before stepping into new roles as Chairman and Member of the Advisory Board. This ensures a seamless transition while preserving the company’s strategic direction and core values.

“We are proud of what we have achieved alongside our dedicated employees and look ahead with confidence. With Ralf Ledda, Leopold Frank, and Christoph Pabst, supported by the entire Hettich Group team, we are certain that the company will continue on its successful trajectory,” Klaus-Günter Eberle.

Looking ahead

With this leadership transition, the Hettich Group is reinforcing its commitment to growth, innovation, and sustainability. The company expresses its gratitude to its employees, customers, and partners for their continued trust and support.

Other news from the department people

Most read news

More news from our other portals

All autoclave manufacturers at a glance

Last viewed contents

Managing Director Peter Sölkner leaves Vetter - Managing Director Carsten Press takes over the relevant departments

Managing Director Peter Sölkner leaves Vetter - Managing Director Carsten Press takes over the relevant departments

Turning fallen leaves into sustainably made paper - Ukrainian scientist selected as a finalist for the Young Inventors Prize 2024

Turning fallen leaves into sustainably made paper - Ukrainian scientist selected as a finalist for the Young Inventors Prize 2024

Lonza Welcomes New Group Chief Executive Officer Wolfgang Wienand - Albert M. Baehny will retire from Lonza Group following a transition period

Lonza Welcomes New Group Chief Executive Officer Wolfgang Wienand - Albert M. Baehny will retire from Lonza Group following a transition period

Dr. Roland Durner becomes new CEO of Bioengineering AG

Dr. Roland Durner becomes new CEO of Bioengineering AG

GDCh Award for Biocatalysis for Sebastian Gergel

GDCh Award for Biocatalysis for Sebastian Gergel

Michael Grosse to succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG - Grosse to take over as Group CEO on July 1, 2025

Michael Grosse to succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG - Grosse to take over as Group CEO on July 1, 2025

WACKER BIOSOLUTIONS under New Leadership - Susanne Leonhartsberger will leave the company at her own request at the end of 2024.

WACKER BIOSOLUTIONS under New Leadership - Susanne Leonhartsberger will leave the company at her own request at the end of 2024.

DMC Biotechnologies announces Dr. Jim Flatt as CEO - DMC seeking to transform how the world makes chemicals

DMC Biotechnologies announces Dr. Jim Flatt as CEO - DMC seeking to transform how the world makes chemicals

Merck: New CEOs for Life Science and Healthcare business sectors and New Chief People Officer - Appointment of three internal senior executives ensures strategic continuity with a new era of leadership

Merck: New CEOs for Life Science and Healthcare business sectors and New Chief People Officer - Appointment of three internal senior executives ensures strategic continuity with a new era of leadership

CureVac appoints new CEO - Dr. Franz-Werner Haas to complete tenure as CEO by March 31, 2023

CureVac appoints new CEO - Dr. Franz-Werner Haas to complete tenure as CEO by March 31, 2023

LenioBio announces new CEO - Founder will be stepping down as CEO

LenioBio announces new CEO - Founder will be stepping down as CEO

T-CURX announces senior leadership appointments - T-CURX completes formation of highly experienced clinical team to rapidly advance clinical translation of its next-generation CAR-T cell therapies

T-CURX announces senior leadership appointments - T-CURX completes formation of highly experienced clinical team to rapidly advance clinical translation of its next-generation CAR-T cell therapies